Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -87,758 | -62,147 | -39,025 | -20,958 | -58,574 |
| Depreciation Amortization | 346 | 226 | 108 | 51 | 3,947 |
| Accounts receivable | 381 | 372 | 236 | 294 | 53,227 |
| Accounts payable and accrued liabilities | -14,158 | -13,433 | -14,707 | -8,418 | -20,969 |
| Other Working Capital | -10,231 | -10,617 | -13,759 | -7,103 | 31,079 |
| Other Operating Activity | 24,403 | 21,410 | 20,108 | 10,975 | -151,679 |
| Operating Cash Flow | $-87,017 | $-64,189 | $-47,039 | $-25,159 | $-142,969 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 37,592 | -2,788 | -2,601 | -17,686 | 268,000 |
| PPE Investments | -1,221 | -1,198 | -985 | -38 | 10,926 |
| Purchase Of Investment | -34,261 | N/A | N/A | N/A | -58,555 |
| Sale Of Investment | N/A | N/A | N/A | N/A | 160,385 |
| Investing Cash Flow | $2,110 | $-3,986 | $-3,586 | $-17,724 | $380,756 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -11,700 | N/A | N/A | N/A | -216,580 |
| Common Stock Issued | 37,084 | 36,705 | 16,924 | 16,947 | 69,970 |
| Common Stock Repurchased | -2,675 | -2,675 | -2,675 | -2,675 | -1,026 |
| Financing Cash Flow | $22,709 | $34,030 | $14,249 | $14,272 | $-147,636 |
| Beginning Cash Position | 126,263 | 126,263 | 126,263 | 126,263 | 36,112 |
| End Cash Position | 64,065 | 92,118 | 89,887 | 97,652 | 126,263 |
| Net Cash Flow | $-62,198 | $-34,145 | $-36,376 | $-28,611 | $90,151 |
| Free Cash Flow | |||||
| Operating Cash Flow | -87,017 | -64,189 | -47,039 | -25,159 | -142,969 |
| Capital Expenditure | -1,221 | -1,198 | -985 | -38 | -87 |
| Free Cash Flow | -88,238 | -65,387 | -48,024 | -25,197 | -143,056 |